Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

IIBR 100

Next Previous
X
Search
Drug Profile

IIBR 100

Alternative Names: BriLife™ COVID vaccine; BriLife™ vaccine; Coronavirus vaccine - NRx Pharmaceuticals; IIBR-100; rVSV-SARS-CoV-2-S vaccine - NRx Pharmaceuticals; rVSV-Sars-CoV2 vaccine - Israel Institute for Biological Research; rVSV-∆G-spike vaccine - NRx Pharmaceuticals; VSV ΔG; VSV-∆G-spike vaccine - NRx Pharmaceuticals

Latest Information Update: 29 Jan 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Israel Institute for Biological Research
  • Class COVID-19 vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II COVID 2019 infections

Most Recent Events

  • 19 Jan 2024 NeuroRx withdraws the BRILIFE001 phase-II/III trial in COVID-2019 infections (Prevention) in Georgia (Intradermal, IM),
  • 08 Mar 2022 IIBR 100 is available for licensing as of 08 Mar 2022. https://www.nrxpharma.com/
  • 11 Jan 2022 Israel Ministry of Health approves a clinical study for NanoPass MicronJet™ intradermal injection system for IIBR 100

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top